1 / 18

Acute Liver Failure in the USA: Results of the US ALF Study Group

Acute Liver Failure in the USA: Results of the US ALF Study Group. William M. Lee, MD Meredith Mosle Distinguished Professor in Liver Disease University of Texas Southwestern Medical Center Dallas, TX www3.utsouthwestern.edu/liver. Acute Liver Failure (ALF): Definition. Altered mentation

sandra_john
Download Presentation

Acute Liver Failure in the USA: Results of the US ALF Study Group

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Acute Liver Failure in the USA: Results of the US ALF Study Group William M. Lee, MD Meredith Mosle Distinguished Professor in Liver Disease University of Texas Southwestern Medical Center Dallas, TX www3.utsouthwestern.edu/liver

  2. Acute Liver Failure (ALF): Definition • Altered mentation • Coagulopathy (INR >1.5) • Acute illness (< 26 wks) • No cirrhosis • Variety of etiologies

  3. Acute Liver Failure (ALF) Background • Orphan disease: ca. 2,000 cases/yr • No one center can study the condition • No viable treatment for all patients • High mortality/morbidity • Transplantation has helped--how much?

  4. Acute Liver Failure Study GroupA consortium to study a rare disease • 14 academic med centers initially in 1998, now 25 • Also 23 pediatric sites, since 2000 • Detailed prospective data and serum samples • N-acetylcysteine trial for non-ACM ALF • Numerous ancillary studies in progress Funded by NIH R03, FDA Orphan Grant, NIH R01 (‘00-’05)

  5. Case Report Form

  6. ALF etiologies: prior US studies (%) * ‘Infectious and serum hepatitis’ Medicine 1969;48:151-72, Dig Dis Sci 1991;36:1223-8, Mayo Clin Proc 1985;60:289-92, Liver Transpl Surg 1999;5:29-34, and Liver Transpl 2000;6:163-9.

  7. Etiology of ALF in the USA(n = 395)

  8. Comparison Between Retrospective Study (1994-96; n = 295) and Current Study (1998-2001; n = 308) + NS

  9. Comparison of Different ALF Etiology Groups Variable Acetaminophen Drug Induced Indeterminate All Others p (n = 120) (n = 40) (n = 53) (n = 95)value Sex (%F) 79 73 60 72 NS Age (yrs) 36 41 38 43 0.02 Jaundice (days) 1 12 12 4 <0.001 Coma III/IV (%) 50 43 47 47 NS ALT 4310 574 947 1060 <0.001 Bilirubin 4.3 20.2 24.5 12.6 <0.001 Tx (%) 6 53 51 36<0.001 Spont surv (%) 68 25 17 33 <0.001 Overall surv (%) 73 70 64 61 NS

  10. ALF etiologies outside the US (%)

  11. Presentations of acetaminophen poisoningAccidental vs. suicidal cases • Suicidal: single time point ingestion with suicidal intent • Accidental: multiple time points, cause for pain, suicidal intent denied

  12. Acetaminophen Toxicity in an Urban County Hospital The Parkland Study: Schiødt et al., NEJM 1997;337:1112-7 All patients admitted with potential ACM injury Accidental Suicidal p-value (n=21) (n=50) Present >24h 64% 14% 0.001 EtOH abuse 63% 25% 0.009 ACM level mg/L 7 126 <0.001 ALT (IU/L) 7430 1501 0.001 ALT ≥1000 IU/L 62% 20% <0.002 Rec’d NAC 76% 80% 0.76 Hepatic coma 33% 6% <0.001 Death 19% 2% 0.04

  13. Acetaminophen Toxicity Leading to ALF Results in 108 patients, 12 deleted • Female 79%, median age 36 (19-63) • Alcohol use: 57%; alcohol abuse: 19% • Narcotic combinations: 38% • Dose ≥ 4 gm/day: 69%; ≥ 10 gm/day: 32% • ACM level detectable: 82%; > 50 mg/L: 42% • ALT > 7,000 IU/L: 51%; ALT > 3,500 IU/L: 92% • Cr ≥ 2.0 52%; pH ≤ 7.3 17%

  14. Suicidal vs. Accidental ACM ALF Cases Accidental Suicidal p-value (n=59) (n=44) Age 39 33 0.011 Tot ACM (g) 20 29 NS Antidepress’t 36% 34% NS EtOH 55% 61% NS Double use 24% 5% 0.02 Narcotic/acet 54% 14% 0.001 ALT (IU/L) 3,616 5,929 <0.001 Creatinine 2.5 1.3 0.008 Survival 71% 75% NS

  15. 308 Patients enrolled Transplanted n= 89 (29%) Died before transplantation n= 87 (28%) Spontaneous survivors n= 132 (43%) Alive (n= 75) Died (n= 14) Outcomes for Acute Liver Failure patients Acetamin.: 30 Indetermin: 20 Drug-induced: 9 Shock liver: 7 Hepatitis B: 4 Malignancy: 4 Pregnancy: 3 Autoimm. hep.: 3 Wilson: 2 Hepatitis A: 2 Budd-Chiari: 1 Others: 2

  16. Summary: Acetaminophen-related ALFConstitutes 1/3 of all US ALF deaths • The most common cause for ALF and a (?growing) problem in US (~150-800/year in US) • Alcohol relationship less apparent • Accidental and suicidal cases similar clinically • Relatively low mortality cf. other ALF causes • Role of anti-depressants 35%, narcotics 38% and repeated daily dosing needs further attention • Pediatric cases also of concern (~20%)

More Related